Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 6/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
| ▸ | HRH1 | P35367 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octinoxate SCHEMBL9295689 | 0.94 | TDP1 (0.64) | TDP1LMNAMAPK1HPGDCYP2C19 | |
| Octinoxate SCHEMBL1408448 | 0.91 | TDP1 (0.84) | TDP1LMNAMAPK1ALDH1A1MAPT | |
| Octinoxate SCHEMBL15823032 | 0.85 | TDP1 (0.77) | TDP1LMNACYP2C19ALDH1A1CYP2D6 | |
| Octinoxate SCHEMBL1768913 | 0.85 | TDP1 (1.00) | TDP1LMNAALDH1A1ATMMEN1 | |
| Octinoxate SCHEMBL15803545 | 0.85 | TDP1 (1.00) | TDP1LMNAALDH1A1ATMMEN1 | |
| Octinoxate SCHEMBL15609 | 0.85 | TDP1 (1.00) | TDP1LMNAALDH1A1ATMMEN1 | |
| Octinoxate SCHEMBL30252195 | 0.85 | TDP1 (1.00) | TDP1LMNAALDH1A1ATMMEN1 | |
| Octinoxate SCHEMBL39360 | 0.85 | TDP1 (1.00) | TDP1LMNAALDH1A1ATMMEN1 | |
| Octinoxate SCHEMBL12533330 | 0.85 | TDP1 (1.00) | TDP1LMNAALDH1A1ATMMEN1 | |
| Oxybenzone SCHEMBL8723921 | 0.84 | LMNA (0.53) | TDP1LMNAMAPK1HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3244971-A1 | USE OF PLANT CELLS OF LEONTOPODIUM ALPINUM FOR A COSMETIC TREATMENT AND CORRESPONDING ACTIVE INGREDIENT | SEDERMA (FR) | 2017-11-22 | — | — | EP | disclosed |
| WO-2016113659-A1 | USE OF PLANT CELLS OF LEONTOPODIUM ALPINUM FOR A COSMETIC TREATMENT AND CORRESPONDING ACTIVE INGREDIENT | SEDERMA (FR) | 2016-07-21 | — | — | WO | disclosed |
| EP-2935529-A1 | LIQUID FUEL COMPOSITIONS COMPRISING ORGANIC SUNSCREEN COMPOUNDS | Shell Internationale Research Maatschappij B.V. (NL) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014149486-A1 | POLYMERS POLYMERIZED FROM AT LEAST FOUR MONOMERS, AND COMPOSITIONS AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014096250-A1 | LIQUID FUEL COMPOSITIONS COMPRISING ORGANIC SUNSCREEN COMPOUNDS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2014-06-26 | — | — | WO | disclosed |
| EP-2701670-A1 | CLEAR WET SPRAYS AND GELS | Isp Investments Inc. (US) | 2014-03-05 | — | — | EP | disclosed |
| US-8524292-B2 | Cosmeceutical formulation containing palm oils | PACIFIC SPECIALTY OILS, INC. (US) | 2013-09-03 | — | — | US | disclosed |
| WO-2012149355-A1 | CLEAR WET SPRAYS AND GELS | ISP INVESTMENTS INC. (US) | 2012-11-01 | — | — | WO | disclosed |
| WO-2012078961-A1 | COMPOSITIONS COMPRISING STABILIZED KETO-ENOL UV ABSORBERS | ISP INVESTMENT INS. (US) | 2012-06-14 | — | — | WO | disclosed |
| US-20090182051-A1 | COSMECEUTICAL FORMULATION CONTAINING PALM OILS | KOPAS, PATRICIA MCKANE | 2009-07-16 | — | — | US | disclosed |
| US-7531196-B2 | Cosmeceutical formulation containing palm oils | PACIFIC SPECIALTY OILS, INC. (US) | 2009-05-12 | — | — | US | disclosed |
| EP-1539098-A4 | COSMETIC COMPOSITION CONTAINING MICROCRYSTALLINE CELLULOSE | FMC CORP (US) | 2008-09-24 | — | — | EP | disclosed |
| WO-2005118759-A1 | COSMECEUTICAL FORMULATION CONTAINING PALM OILS | KOPAS PATRICIA MCKANE (US) | 2005-12-15 | — | — | WO | disclosed |
| EP-1539098-A2 | COSMETIC COMPOSITION CONTAINING MICROCRYSTALLINE CELLULOSE | FMC CORPORATION (US) | 2005-06-15 | — | — | EP | disclosed |
| US-20040241254-A1 | Cosmeceutical formulation containing palm oils | PACIFIC SPECIALTY OILS, INC. | 2004-12-02 | — | — | US | disclosed |
| WO-2004026263-A2 | COSMETIC COMPOSITION CONTAINING MICROCRYSTALLINE CELLULOSE | FMC CORPORATION (US) | 2004-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182051-A1 | COSMECEUTICAL FORMULATION CONTAINING PALM OILS | CUTA, SCD, SCD5 | TDP1 564/4885LMNA 1355/4885MAPK1 4295/4885 |
| US-20040241254-A1 | Cosmeceutical formulation containing palm oils | CUTA, SCD, SCD5 | TDP1 564/4885LMNA 1355/4885MAPK1 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.